Live feed
Filing
SC 13G
SC 13G0001042167-23-000059·CYTOVANCE BIOLOGICS INC
Schedule 13G ownership disclosure
GT BIOPHARMA INC
Security class unavailable · CUSIP: 36254L209
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,755,817
- Percent of class
- 6.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001042167-23-000059
- Form type
- SC 13G
- Filer
- CYTOVANCE BIOLOGICS INC
- CIK
- CIK 1231100
- Filed
- Sep 19, 2023
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership